Citation Impact
Citing Papers
Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
2006 Standout
QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy
2005
The Medical Management of Depression
2005
Antidepressant Drug Effects and Depression Severity
2010 Standout
Influence of Patients’ Requests for Direct-to-Consumer Advertised Antidepressants
2005 Standout
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
2018 Standout
Depression
2018 Standout
Effect of Sedation With Dexmedetomidine vs Lorazepam on Acute Brain Dysfunction in Mechanically Ventilated Patients
2007 Standout
Major depressive disorder
2016 Standout
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
2015
Glutamate receptor ion channels
2005 Standout
Child abuse: Adolescent records vs. adult recall
1990 Standout
Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes
2007
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Functional Bowel Disorders
2006 Standout
Pharmacokinetics of selective serotonin reuptake inhibitors
2000
Blonanserin
2009
Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release
2006
Depression in Patients With Lung Cancer: Prevalence and Risk Factors Derived From Quality-of-Life Data
2000
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
2011
Increased global integration in the brain after psilocybin therapy for depression
2022
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
2009
SSRI Antidepressant Medications
2001
Childhood Abuse, Household Dysfunction, and the Risk of Attempted Suicide Throughout the Life Span
2001 Standout
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
Clinical Response to Tricyclic Antidepressants in Functional Bowel Disorders is not Related to Dosage
2005
Adherence to Drugs That Prevent Cardiovascular Disease: Meta-analysis on 376,162 Patients
2012
Exercise Standards for Testing and Training
2013 Standout
Physicians' attitudes to and problems with truth-telling to cancer patients
2000
How do antidepressants work? New perspectives for refining future treatment approaches
2017
Network pharmacology: the next paradigm in drug discovery
2008 Standout
A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia
2008
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
2012
Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death
2009
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
2010 Standout
Neurological bases for balance–anxiety links
2001
Antipsychotic-Induced Hyperprolactinemia
2008
Sleep disruption in critically ill patients – pharmacological considerations
2004
Communicating sad, bad, and difficult news in medicine
2004 Standout
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
High-performance medicine: the convergence of human and artificial intelligence
2018 Standout
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research.
2016 Standout
Hot flushes
2002
Drug repurposing: progress, challenges and recommendations
2018 Standout
The Serotonin Syndrome
2005 Standout
Brain correlates of music-evoked emotions
2014 Standout
Myocarditis
2011 Standout
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Amisulpride Overdose Is Frequently Associated With QT Prolongation and Torsades de Pointes
2010
Major Depressive Disorder
2008 Standout
The neural basis of psychedelic action
2022 Standout
Hyperprolactinemia and Prolactinomas
2008
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Augmentation strategies for treatment-resistant depression
2008
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole
2008
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance Treatment of Major Depressive Disorder and Treatment of Chronic Depressive Disorders and Subthreshold Depressions
2002
Health outcomes of bereavement
2007 Standout
Predictable and Less Predictable Unwanted Cardiac Drugs Effects: Individual Pre‐Disposition and Transient Precipitating Factors
2010
Osteoarthritis
2019 Standout
Depression and anxiety in women with early breast cancer: five year observational cohort study
2005 Standout
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
HPA axis and aging in depression: Systematic review and meta-analysis
2013
Clinically Significant Drug Interactions with Newer Antidepressants
2011
New atypical antipsychotics for schizophrenia: iloperidone
2010
Myocarditis
2009 Standout
A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis
2018
Comparative Benefits and Harms of Second-Generation Antidepressants: Background Paper for the American College of Physicians
2008
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
The Stressful Caregiving Adult Reactions to Experiences of Dying (SCARED) Scale: A Measure for Assessing Caregiver Exposure to Distress in Terminal Care
2003
Antidepressants and the serotonin syndrome in general practice.
1999
Magnesium in Man: Implications for Health and Disease
2014 Standout
Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder
2008
Review of sertraline and its clinical applications in psychiatric disorders
2001
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2006
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Childhood Abuse, Neglect, and Household Dysfunction and the Risk of Illicit Drug Use: The Adverse Childhood Experiences Study
2003 Standout
Definition, Assessment, and Staging of Treatment—Resistant Refractory Major Depression: A Review of Current Concepts and Methods
2007
Interventions for enhancing medication adherence
2014 Standout
Perphenazine for schizophrenia
2015
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Effects on prolongation of Bazett’s corrected QT interval of seven second-generation antipsychotics in the treatment of schizophrenia: a meta-analysis
2010
Risky families: Family social environments and the mental and physical health of offspring.
2002 Standout
Antipsychotic Drugs and the Risk of Ventricular Arrhythmia and/or Sudden Cardiac Death: A Nation‐wide Case‐Crossover Study
2015
Subcellular Partitioning and Intramacrophage Selectivity of Antimicrobial Compounds against Mycobacterium tuberculosis
2017 StandoutNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Chiral Diarylmethanes via Copper-Catalyzed Asymmetric Allylic Arylation with Organolithium Compounds
2015 StandoutNobel
Homeostasis, Stress, Trauma, and Adaptation
1998
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines
2000
Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews
2014
Risk of Mortality (Including Sudden Cardiac Death) and Major Cardiovascular Events in Atypical and Typical Antipsychotic Users: A Study with the General Practice Research Database
2013
Works of Peter Haddad being referenced
Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional research.
2006
Serotonin Reuptake Inhibitor Discontinuation Syndrome: A Hypothetical Definition
1997
An Overview of The Definition and Management of Treatment-Resistant Depression
2002
Possible Biological Mechanisms of the Serotonin Reuptake Inhibitor Discontinuation Syndrome
1997
Study protocol for the randomised controlled trial: Antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study)
2013
The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study
2008
Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia
2010
Compliance with antidepressant therapy and antidepressant discontinuation symptoms
2000
Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial
2015
The impact of cancer on key relatives: A comparison of relative and patient concerns
1995
Antipsychotic-Related QTc Prolongation, Torsade de Pointes and Sudden Death
2002
Hyperkinetic Syndrome and Disruptive Early Experiences
1992
Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder
2005
The use of antidepressants in clinical practice: focus on agomelatine
2010
Antidepressant Discontinuation Syndromes
2001
Adverse Effects of Atypical Antipsychotics
2007
Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences
2003
Antipsychotic-Induced Hyperprolactinaemia
2004
Selecting antipsychotics in schizophrenia: lessons from CATIE
2006
Recognising and managing antidepressant discontinuation symptoms
2007
Medicines adherence: Involving patients in decisions about prescribed medicines and supporting adherence
2009
Do antidepressants have any potential to cause addiction?
1999
The SSRI discontinuation syndrome
1998
Newer antidepressants and the discontinuation syndrome.
1997
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
2015
Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel.
1997
Effect of mode of breast cancer diagnosis on subsequent affective disorder
1994
Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel.
1997